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A TRAF6-ECSIT complex is crucial for the generation of mitochondrial reactive
oxygen species (mROS) and nuclear factor-kappa B (NF-κB) activation induced by
Toll-like receptor 4 (TLR4). Peroxiredoxin-6 (Prdx6) as a member of the peroxiredoxin
family of antioxidant enzymes is involved in antioxidant protection and cell signaling.
Here, we report on a regulatory role of Prdx6 in mROS production and NF-κB
activation by TLR4. Prdx6 was translocated into the mitochondria by TLR4 stimulation
and Prdx6-knockdown (Prdx6KD) THP-1 cells had increased level of mitochondrial
reactive oxygen species levels and were resistant to Salmonella typhimurium infection.
Biochemical studies revealed Prdx6 interaction with the C-terminal TRAF-C domain
of TRAF6, which drove translocation into the mitochondria. Interestingly, Prdx6
competitively interacted with ECSIT to TRAF6 through its C-terminal TRAF-C domain,
leading to the interruption of TRAF6-ECSIT interaction. The inhibitory effect was critically
implicated in the activation of NF-κB induced by TLR4. Overexpression of Prdx6 led
to the inhibition of NF-κB induced by TLR4, whereas Prdx6KD THP-1 cells displayed
enhanced production of pro-inflammatory cytokines including interleukin-6 and -1β,
and the up-regulation of NF-κB-dependent genes induced by TLR4 stimulation. Taken
together, the data demonstrate that Prdx6 interrupts the formation of TRAF6-ECSIT
complex induced by TLR4 stimulation, leading to suppression of bactericidal activity
because of inhibited mROS production in mitochondria and the inhibition of NF-κB
activation in the cytoplasm.
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INTRODUCTION
Reactive oxygen species (ROS) are a component of the killing response to microbial invasion
and a mediator of cell signal transduction (Lambeth, 2004; Vogel et al., 2007; West et al., 2011).
Phagocytes including macrophages and dendritic cells are specialized cells of the innate immune
system, which are designed to engulf and destroy harmful microorganisms in phagosomes (Beutler
et al., 2006; West et al., 2006, 2011). Phagocytes produce large quantities of ROS primarily
via the phagosomal nicotinamide adenine dinucleotide phosphate (NADPH) oxidase machinery
(Lambeth, 2004; Vogel et al., 2007). In addition, the mitochondrial oxidative phosphorylation
machinery also contributes to macrophage bactericidal activity through the production of
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mitochondrial ROS (mROS) (Murphy, 2009; Koopman et al.,
2010; West et al., 2011; Geng et al., 2015). The molecular and
cellular mechanism by which mROS production is regulated
in the mitochondria and is functionally associated with innate
immune signaling remain unclear. Two recent reports showed
that signals of Toll-like receptors (TLRs) are critical for effective
phagosome-mitochondrion function and bactericidal activity
(West et al., 2011; Geng et al., 2015). The data revealed that
engagement of TLRs in macrophages led to the translocation
of mitochondria to phagosomes, which was mediated by
the assembly of a complex of the ubiquitin ligase tumor
necrosis factor receptor-associated factor 6 (TRAF6) and the
mitochondrial complex I–evolutionarily conserved signaling
intermediate in Toll pathways (ECSIT), which augmented mROS
production and bactericidal activity. In addition, the Mst1 and
Mst2 kinases were demonstrated to positively regulate phagocytic
induction of ROS and bactericidal activity by promoting TLR-
triggered assembly of TRAF6-ECSIT complex (Geng et al., 2015).
These results strongly suggest that the functional assembly of
TRAF6-ECSIT complex in the mitochondria plays a pivotal role
for the production of mROS, and thereby leads to the bactericidal
activity.
Beyond the functional role of TRAF6-ECSIT complex in the
mitochondria, the complex has also been critically implicated
in the activation of nuclear factor-kappa B (NF-κB) induced
by TLR stimulation (Kopp et al., 1999; Wi et al., 2014; Mi
Wi et al., 2015). ECSIT has been identified and functionally
characterized as a novel intermediate in the Toll/Interleukin
(IL)-1 signal transduction pathways that bridge TRAF6 to
mitogen-activated protein kinase/extracellular signal-regulated
kinasekinase-1 (MEKK-1) (Kopp et al., 1999). The adapter ECSIT
protein regulates the processing of MEKK-1, which leads to the
activation of NF-κB induced by the Toll/IL-1 pathways. Our
recent studies have suggested a new regulatory role of ECSIT in
the TLR4-mediated signal for the activation of NF-κB (Wi et al.,
2014; Mi Wi et al., 2015). In this scenario, ECSIT forms a TAK1-
ECSIT-TRAF6 complex induced by TLR4 stimulation, which
plays a key role for the activation of NF-κB through the regulation
of TAK1 activation (Wi et al., 2014). Moreover, we found that
the ubiquitinated ECSIT by TRAF6 specifically interacts with
p65/p50 NF-κB components through the ubiquitination chain
at the K372 residue of ECSIT, and then the ECSIT/p65/p50
complex leads to the translocation into the nucleus, resulting in
the regulation of NF-κB-dependent gene expression (MiWi et al.,
2015).
Peroxiredoxin-6 (Prdx6) is the prototype and the only
mammalian 1-Cys Prdx member (Rhee et al., 2001; Woo et al.,
2003). Prdx6 has been widely studied in cells and animal
models for its antioxidant properties (Wood et al., 2003; Rhee
et al., 2005), which provides protection against the harmful
consequences of oxidative stress (Chen et al., 2000). Its expression
has been described in several cell compartments including the
cytoplasm, secretory organelles, and lysosomes (Immenschuh
and Baumgart-Vogt, 2005; Wu et al., 2006; Liu et al., 2012).
After ischemia or ischemia/reperfusion (I/R) injury, in which
the production of ROS induced by TLR activation is one
of the most important factors in the pathogenesis (Jaeschke
et al., 1988; Tsung et al., 2005; Evankovich et al., 2010), Prdx6
expression is lost in the cytoplasm and markedly increases in
the mitochondria (Eismann et al., 2009). Although the molecular
mechanism is as yet largely unexplored, deletion of Prdx 6
exacerbates lipopolysaccharide (LPS)-induced acute lung injury
and inflammation with increased oxidative stress, inflammatory
responses, and matrix degradation, all of which are partially
dependent on the NF-κB, extracellular signal-regulated kinase,
and c-Jun N-terminal kinase pathways (Yang et al., 2011).
Here we show that Prdx6 is critically implicated in bactericidal
activity and NF-κB activity induced by TLR4. Prdx6 involved
these processes through the molecular association with TRAF6.
Prdx6-TRAF6 interaction inhibited the association of ECSIT
to TRAF6 in the mitochondria and cytoplasm, leading to
suppression of mROS generation and NF-κB activation mediated
by the TRAF6-ECST complex.
MATERIALS AND METHODS
Cell Lines and Reagents
HEK293T cells (ATCC, Rockville, MD) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM, Gibco, Detroit,
MI) supplemented with 10% fetal bovine serum (FBS, Gibco).
293/TLR4 cells (293/TLR4-MD2-CD14, Invivogen, San Diego,
CA) were cultured in DMEM supplemented with 10mg/mL
blasticidin and 50mg/mL HygroGold (Invivogen) as per the
manufacturer’s instruction. THP-1 human monocytic leukemia
cells (ATCC) were maintained in RPMI 1640 supplemented
with 10% FBS, penicillin–streptomycin, and β-mercaptoethanol.
Lentivirus containing small hairpin RNA (shRNA) targeting
human Prdx6 (sc-62896-V) and control shRNA lentivirus
(sc-108080) were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). THP-1 cells were cultured in wells of a
24-well plate (2 × 105 cells/well) and infected with control
shRNA lentivirus for the generation of control (Ctrl) THP-1
cells and lentivirus containing shRNA targeting human Prdx6
for the generation of Prdx6 knockdown (Prdx6KD) THP-1
cells, respectively, according to the manufacturer’s protocol.
Cells were maintained in puromycin-containing (4–8 µg/ml)
medium. MitoTracker Green FM was obtained from Thermo
Fisher Scientific (Waltham, MA). The following antibodies
and reagents were used: Prdx6 (Abcam, Cambridge, MA),
GRIM19 (Abcam), Myc (Cell Signaling Technology, Beverley,
MA), Flag, (Cell Signaling Technology), TRAF6 (Cell Signaling
Technology), ECSIT (Abcam), 4′,6′-diamindino-2-phenylindole
(DAPI; Thermo Fisher Scientific), MitoSOX Red (Molecular
Probes, Invitrogen, Carlsbad, CA), CM-H2DCFDA (Invitrogen),
and lipopolysaccharide (LPS, L6143; Sigma-Aldrich, St. Louis,
MO).
Cellular Fractionation and Mitochondrial
Isolation
293/TLR4 cells were stimulated with or without 500 ng/ml
LPS for different times (0, 15, 30, 45, 60min). Cellular
fractionation and mitochondrial isolation protocol was carried
out as previously described (West et al., 2011).
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ROS Measurements and Staining
Control (Ctrl) and Prdx6KD THP-1 cells were treated with
or without 500 ng/ml LPS for 60min. Culture medium was
removed, cells were washed with phosphate buffered saline
(PBS) then incubated with MitoSOX Red (to measure the
mROS superoxide) and/or 5-(and-6)-chloromethyl-2′,7′-
dichlorodihydrofluorescein diacetate (CM-H2DCFDA, to
measure total cellular H2O2) at 2.5 µM final concentration in
serum-free RPMI 1640 for 15 to 30 min at 37◦C. Cells were
washed with warmed PBS (37◦C), removed from plates with
cold PBS containing 1mM EDTA by pipetting, pelleted at
1,500 rpm for 3min, immediately re-suspended in cold PBS
containing 1% FBS, and subjected to fluorescence-activated
cell sorting (FACS) analysis using a FACScalibur apparatus
(Becton Dickinson, San Diego, CA). All ROS experiments shown
are representative of three independent experiments. For the
immunofluorescence microscopy, cells were mounted with
Prolong Gold anti-fade reagent (Molecular Probes) and imaged
on a LSM 710 laser-scanning confocal microscope (Carl Zeiss,
Jena, Germany).
Immunofluorescence Confocal Microscopy
For all microscopy images, 293/TLR4 cells were grown on
coverslips and stimulated with or without 500 ng/ml LPS
for 30min and stained with MitoTracker FM (Invitrogen
Ltd, Paisley, UK). After washing, cells were fixed with 4%
paraformaldehyde for 20 min, permeabilized with 0.1% Triton
X-100 in PBS for 5min, blocked with PBS containing 10%
FBS for 30min, and stained with primary antibodies (anti-
Prdx6). Cells were then stained with secondary antibody, Alexa
Fluor R© 647 anti-Mouse IgG (H+L) (Jackson ImmunoResearch
Laboratories). Cells were stained with 4′,6-diamidino-2-
phenylindole (Sigma-Aldrich) and mounted with Prolong Gold
anti-fade reagent (Molecular Probes). Cells were imaged on a
LSM 710 laser-scanning confocal microscope (Carl Zeiss). The
overlap coefficient were calculated using the ZEN 2011 program,
which evaluated more than ten cells from three images for each
condition.
Salmonella Infection Assay
Salmonella infection protocol was previously described (Blanc-
Potard and Groisman, 1997; Valle and Guiney, 2005). Briefly,
5 × 105 THP-1 cells were cultured in fresh RPMI 1640
complete medium without antibiotics for 1 day, and treated
with 12-O-tetradecanoylphorbol-13-acetate (PMA, 20 ng/ml)
and seeded into culture wells at a concentration of 7 × 105
cells/ml. The next day, nonadherent cells were removed and
replaced with fresh complete medium without antibiotics. The
cells were infected with Salmonella typhimurium wild type
(14028s strain) at a multiplicity of infection of 10 bacteria/cell.
Culture plates were centrifuged at 200 × g for 5 min and
incubated at 37◦C for 30min to allow phagocytosis to occur.
The medium was then replaced with fresh medium containing
gentamicin (20 µg/ml) and incubated for different times.
The total cell population in the well was harvested. An
aliquot of the harvested cell population was centrifuged, the
macrophages were lysed by 0.5% deoxycholate in Dulbecco’s
PBS, and the bacteria were diluted and plated on LB agar.
The percentage survival was obtained by dividing the number
of bacteria recovered after 6 h or 12 h by the number
of bacteria present at time 0 and multiplying by 100. All
experiments were done in duplicate on at least three independent
occasions.
Plasmids
The following plasmids were used: Flag-tagged TRAF6, Flag-
tagged ECSIT, Myc-tagged ECSIT and Myc-tagged Prdx6, as
previously described (Kim et al., 2014; Wi et al., 2014; Mi Wi
et al., 2015; Moon et al., 2015). Flag-tagged TRAF6 truncated
mutants were generated with specific primers as described in the
Supplementary Information.
Western Blotting and Immunoprecipitation
Assay
Western blotting and immunoprecipitation were performed
as described previously (Kim et al., 2012, 2014; Yong Kim
et al., 2013; Lee et al., 2016). Briefly, HEK293T cells were
co-transfected with the designated vectors, as indicated
in the Figures. After 38 h, the cells were extracted and
immunoprecipitated with anti-Flag or anti-Myc antibody,
followed by immune blotting with antibodies to anti-
Myc, or anti-Flag. For endogenous immunoprecipitation
assay, Ctrl THP-1 and Prdx6KD THP-1 cells were treated
with or without LPS (500 ng/ml) for 60min, respectively.
immunoprecipitation assay was performed in lysates with
IgG antibody and anti-TRAF6 antibody, and then IB assay
was performed with anti-TRAF6, anti-ECSIT, and anti-Prdx6
antibodies.
Measurement of Proinflammatory
Cytokines and NF-κB DNA-Binding Assay
Ctrl THP-1 or Prdx6KD THP-1 cells were untreated or
treated with LPS (200 ng/ml) for 9 h and the supernatants
were harvested. The levels of human IL-1β and IL-6 were
measured in the supernatants according to the manufacturer’s
protocol (R&D Systems, Minneapolis, MN). Ctrl THP-1
or TRAF6KD THP-1 cells were transiently transfected with
vector control, Flag-TRAF6, or Myc-Prdx6 using Neon
transfection system (Invitrogen). At 36 h post-transfection,
the cells were untreated or treated with LPS (200 ng/ml)
for 9 h and the supernatants were harvested. The level of
human IL-6 was measured in the supernatants according
to the manufacturer’s protocol (R&D Systems). For p65-
or p50-DNA-binding assay, Ctrl THP-1 or Prdx6KD THP-1
cells were treated for 6 h with or without LPS (200 ng/ml),
and then nuclear proteins were prepared with the CelLytic
NuCLEAR extraction kit in accordance with the manufacturer’s
protocol (Sigma-Aldrich). Activities of the transcription
factors p65 or p50 were determined with the TransAM
NF-κB transcription factor assay kit according to the
manufacturer’s instructions (Active Motif North America,
Carlsbad, CA).
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NF-κB-Dependent Luciferase Reporter
Assay
Ctrl THP-1 and Prdx6KD THP-1 cells were transiently transfected
with different vectors including vector control, Myc-Prdx6, Flag-
ECSIT, and Flag-TRAF6, as indicated in the Figures, using Neon
transfection system (Invitrogen), together with the pBIIx-luc NF-
κB-dependent reporter construct and the Renilla luciferase vector
(Promega,Madison,WI). At 36 h post-transfection, the cells were
untreated or treated with LPS (200 ng/ml) for 6 h and lysed, and
luciferase activity was measured using a dual luciferase assay kit
(Promega).
Microarray Analysis
Microarray analysis, raw data preparation, and statistical analysis
were performed as described previously (Oh et al., 2011; Kim
et al., 2012). The protocols are described in detail in the
Supplementary Information.
RNA Isolation and qRT–PCR Analyses
Control (Ctrl) and Prdx6KD THP-1 cells were untreated or
treated with LPS (200 ng/ml) for different times (0, 6, 9 h).
Total RNA was using TRIzol method (Invitrogen) and then was
reverse-transcripted to single strand cDNA using amfiRivert
II cDNA Synthesis Master Mix (GenDEPOT, Barker, TX)
according to the manufacturer’s instructions. Primers used
in this experiment were purchased from Qiagen (Valencia,
CA): hIL-1β (PPH00171C-200), hIL-8 (PPH00568A-200),
hNFKB1 (PPH00204F-200), hCD44 (PPH00114A-200), hRELB
(PPH00287A-200), and hCCL5 (PPH00703B-200). Tag PCR
Master Mix (Qiagen) was used according to the manufacturer’s
protocols to perform RT-PCR reactions on QIAGEN’s real-time
PCR cycler, the Rotor-Gene Q. The amplification reactions were
performed with the following conditions: 5min at 95◦C, 45 cycles
of 95◦C for 15 s, 55◦C for 40 s, 72◦C for 30 s. All quantitative
measurements were carried out in triplicate and normalized
to the internal glyceraldehyde-3-phosphatedehydrogenase
(GAPDH) control for every reaction. Results were represented
as mean value± SEM of the mean from triplicate samples.
Statistical Analysis
In vitro data are presented as mean ± SEM of the mean from
triplicate samples. Statistical differences were analyzed by either
ANOVA or Student’s t-test using GraphPad Prism 5.0 (GraphPad
Software, San Diego, California).
RESULTS
Prdx6 Is a Negative Regulator of mROS
Generation and Is Involved in Bactericidal
Activity
After ischemia or I/R, Prdx6 expression no longer occurs
in the cytoplasm and appears in the mitochondria (Eismann
et al., 2009). The authors also reported that the increased
hepatocellular injury in Prdx6-knockout mice was critically
associated with increased mitochondrial generation of hydrogen
peroxide (H2O2), implicating the mitochondrial trafficking of
Prdx6 with mROS generation. Additionally, it has been reported
that the generation of mROS is regulated by TLR stimulation and
is involved in bactericidal activity (West et al., 2011; Geng et al.,
2015). Based on these previous results, we examined whether the
mitochondrial trafficking of Prdx6 could be also regulated by TLR
stimulation and be involved in mROS generation. 293/TLR4 cells
were not stimulated or were stimulated with LPS, a TLR4 agonist,
for different times, and the cytoplasm andmitochondria fractions
were isolated. Immunoblotting predominantly revealed Prdx6 in
the cytoplasm with marginal detection in the mitochondria in
the absence of LPS (Figure 1A, lanes 1 and 6). In the presence
of LPS stimulation the mitochondrial content of Prdx6 was
significantly increased (Figure 1A, lane 8). Consistent with this,
confocal microscopy revealed mitochondrial trafficking of Prdx6.
Upon LPS stimulation, Prdx6 was significantly co-localized with
MitoTracker Green FM (Figure 1B, without LPS vs. with LPS in
overlay), suggesting that the mitochondrial trafficking of Prdx6 is
induced by TLR4 stimulation.
To correlate the mitochondrial trafficking of Prdx6 induced
by TLR4 with mROS generation, we generated control (Ctrl)
THP-1 cells and Prdx6-knockdown (Prdx6KD) THP-1 cells using
control shRNA lentivirus and Prdx6 shRNA-containing lentiviral
particles, respectively (Figure S1). Consistent with a previous
report (West et al., 2011), the mROS level was significantly
increased by TLR4 stimulation (Figures 1C,D, without LPS vs.
with LPS in Ctrl THP-1). We found that the mROS level
was significantly higher in Prdx6KD THP-1 cells than in Ctrl
THP-1 cells in the absence of TLR4 stimulation (Figures 1C,D,
Ctrl vs. Prdx6KD THP-1 cells without LPS). According to LPS
stimulation, interestingly, the levels were markedly elevated
in the Prdx6KD THP-1 cells, as compared to Ctrl THP-1
cells (Figures 1C,D, Ctrl vs. Prdx6KD THP-1 cells with LPS).
Moreover, the levels of cellular H2O2 were also significantly
higher in Prdx6KD THP-1 cells than in Ctrl THP-1 in the
absence or presence of LPS stimulation (Figure S2), supporting
the functional role of Prdx6 as a cellular anti-oxidant enzyme
capable of neutralizing cellular H2O2. These results suggest that
Prdx6 is translocated into the mitochondria by TLR4 stimulation
and is negatively implicated in the production of mROS in the
mitochondria.
mROS plays an important for the macrophage bactericidal
activity (Murphy, 2009; Koopman et al., 2010; West et al.,
2011; Geng et al., 2015). Having shown that Prdx6KD THP-
1 cells had increased mROS (Figures 1C,D), we examined the
functional effect of Prdx6 in bactericidal activity. Ctrl or Prdx6KD
THP-1 cells were infected with the gram-negative, facultative
intracellular pathogen Salmonella typhimurium, and survival of
the bacterium was measured. The number of colonies at T = 0
was similar in both controls and Prdx6KD cells, as represented
in Figure 2, suggesting that the Prdx6-knockdown did not affect
the initial invasion and uptake of S. typhimurium. Interestingly,
the number of colonies was significantly increased in Ctrl THP-1
cells in a time-dependent manner, whereas a significant decrease
was evident in Prdx6KD THP-1 cells (Figure 2, Ctrl vs. Prdx6KD).
In addition, the survival of S. typhimurium was significantly
attenuated in Prdx6KD THP-1 cells (Figure 2, Ctrl vs. Prdx6KD).
Together these results suggest that Prdx6 as a negative regulator
of mROS may be implicated in bactericidal activity, although
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FIGURE 1 | Peroxiredoxin-6 negatively regulates mROS production in the mitochondria. (A) 293/TLR4 cells were stimulated with LPS (500 ng/ml) for the
indicated times, cells were fractionated and extracts were western-blotted with antibodies for Prdx6, tubulin, or GRIM19. #Densitometry data (normalized to
GRIM19). (B) 293/TLR4 cells were unstimulated or stimulated with LPS (500 ng/ml) for 30min, fixed, immunostained with Mito Tracker (green) and anti-Prdx6 (red),
and counterstained with 4′, 6-diamono-2-phenylindole (DAPI; blue). Data are representative of three independent replicates; scale bar, 10 µm. (C) Ctrl and Prdx6KD
THP-1 cells were unstimulated or stimulated with LPS (500 ng/ml) for 60min, stained with MitoSOX (mitochondria ROS, mROS) and analyzed by immunofluorescence
microscopy. Data are representative of three independent replicates. (D) Ctrl and Prdx6KD THP-1 cells that were unstimulated or stimulated with LPS (500 ng/ml) for
60min, stained with MitoSOX and analyzed by FACS. All error bars represent ± SEM of the mean fluorescence intensity (M.F.I) from triplicate samples. #p = 0.0008,
##p = 0.0002.
FIGURE 2 | Salmonella survival assay in Prdx6-knockdown THP-1 cells. Control (Ctrl) and Prdx6-knockdown (Prdx6KD) THP-1 cells were infected with
Salmonella wild type (14028s strain) at a multiplicity of infection of 10 bacteria/cell as described in Methods. Cells were lysed by 0.5% deoxycholate in Dulbecco’s
PBS, and the bacteria were diluted (x 50) and plated on LB agar. The number of colonies was counted and represented. The number of colonies at T = 0 was
represented as an average of both cell lines, controls and Prdx6KD cells. The percentage survival was obtained by dividing the number of bacteria recovered after 6 h
(T6) or 12 h (T12) by the number of bacteria present at time 0 (T0) and multiplying by 100. All error bars represent ± SEM of three independent experiments. #p =
0.00013, ##p = 0.00037, ###p = 0.00003, ####p = 0.00004.
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the molecular mechanism by which Prdx6 is involved in the
production of mROS induced by TLR4 stimulation is needed to
be provided.
Prdx6 Interacts with TRAF6 and Leads to
Mitochondrial Localization
Having shown the effects of Prdx6 on mROS generation and
bactericidal activity, we next explored the molecular mechanism
by which Prdx6 is negatively involved in the production of
mROS. A previous report has shown that the engagement of
TLRs leads to the translocation of mitochondria to phagosomes,
mediated by the assembly of a complex of the ubiquitin
ligase TRAF6 and the mitochondrial complex I–assembly factor
ECSIT, which results in augmentation of mROS production
and bactericidal activity (West et al., 2011). Therefore, we
raised a possibility that Prdx6 is involved in the assembly
of TRAF6-ECSIT complex. To examine the possibility, Flag-
TRAF6 was transiently expressed into HEK293T cells along with
Myc-ECSIT or Myc-Prdx6, and then an immunoprecipitation
assay was performed with anti-Flag antibody. Myc-ECSIT or
Myc-Prdx6 was significantly co-precipitated with Flag-TRAF6
(Figures 3A,B, respectively), whereas no significant interaction
between Myc-Prdx6 and Flag-ECSIT could be seen (Figure S3).
To confirm whether Prdx6 and TRAF6 proteins are translocated
into the mitochondria in response to LPS stimulation, 293/TLR4
cells were stimulated with or without LPS, and the cellular
localizations of Prdx6 and TRAF6 into the mitochondria were
assessed by confocal microscopy. Consistent with a previous
report (West et al., 2011), the localization of TRAF6 into
mitochondria was increased in the presence of LPS stimulation,
as compared to that in the absence of LPS stimulation (Figures
S4A,B, Mito/TRAF6). The overlap coefficient to quantify the
co-localization was significant (Figures S4A,B, Mito/TRAF6:
0.48 ± 0.04 in without LPS vs. 0.77 ± 0.07 in with LPS).
Consistent with Figure 1B, Prdx6 was significantly co-localized
with mitochondria marker in the presence of LPS stimulation
(Figures S4A,B, Mito/Prdx6: 0.38 ± 0.08 in without LPS vs. 0.68
± 0.05 in with LPS). Based on these results, we supposed that, if
Prdx6 is involved in the mROS production through the assembly
of TRAF6-ECSIT complex in mitochondria (West et al., 2011), it
might be related with the TRAF6 protein.
Prdx6 Interrupts the Interaction between
TRAF6 and ECSIT
To investigate whether Prdx6 is affected on the formation of
TRAF6-ECSIT complex, we first determine the interaction site
of TRAF6 to ECSIT or Prdx6. In order to do that, TRAF6
truncated mutants were generated (Figure 3C), as described
in Materials and Methods. Flag-TRAF6 wild type (wt) and
Flag-tagged truncated mutants of TRAF6 were transfected
with Myc-Prdx6 or Myc-ECSIT, and then immunoprecipitation
assay was performed with anti-Myc or anti-Flag antibody.
Interestingly, Myc-Prdx6 efficiently precipitated Flag-TRAF6 wt
and all truncated mutants of TRAF6 (Figure 3D). Moreover,
Flag-TRAF6 wt and all truncated mutants were specifically
precipitated with Myc-ECSIT (Figure 3E). These results indicate
that Prdx6 or ECSIT interacts with the C-terminal TRAF-
C domain of TRAF6 (Figure 3F). To confirm the specific
interaction, Myc-Prdx6 or Myc-ECSIT was transfected into
HEK293T cells along with Flag-TRAF6 349-522 containing the
TRAF-C domain of TRAF6, and then immunoprecipitated using
an anti-Flag antibody. Consistently, Flag-TRAF6 349-522 was
specifically precipitated with Myc-Prdx6 (Figure 4A) or Myc-
ECSIT (Figure 4B).
Next, we examined whether Prdx6 and ECSIT are
competitively interacted with the TRAF-C domain of TRAF6.
Flag-TRAF6 and Myc-ECSIT were transiently transfected into
HEK293T cells with different concentrations of Myc-Prdx6,
and then immunoprecipitated using an anti-Flag antibody.
As expected, Flag-TRAF6 strongly precipitated Myc-ECSIT in
the absence of Myc-Prdx6 (Figure 4C, lane 2). Interestingly,
the interactions between Flag-TRAF6 and Myc-ECSIT were
greatly attenuated in the presence of Myc-Prdx6, whereas
significant dose-dependent increases of the interaction between
Flag-TRAF6 and Myc-Prdx6 could be observed (Figure 4C,
lanes 2–5), strongly suggesting that Prdx6 and ECSIT are
competitively interacted with the TRAF-C domain of TRAF6.
To verify the effect of Prdx6 on ECSIT-TRAF6 interaction upon
LPS stimulation, endogenous IP assay was performed in Ctrl
THP-1 and Prdx6KD THP-1 cells in the presence or absence of
LPS stimulation. Ctrl THP-1 and Prdx6KD THP-1 cells were
treated with or without LPS, and then immunoprecipitation
assay was performed with anti-TRAF6 antibody. Consistent with
previous reports, endogenous ECSIT protein was significantly
pull-downed with endogenous TRAF6 in the presence of LPS
stimulation (Figure 4D, lane 3). Interestingly, the endogenous
interaction between ECSIT and TRAF6 were significantly
increased in the Prdx6KD THP-1 cells, as compared with that
of Ctrl THP-1 cells (Figure 4D, lane 3 vs. lane 6). As depicted
in Figure 4E, collectively, these results suggest that Prdx6
interacts with TRAF6 via its TRAF-C domain, and the Prdx6-
TRAF6 complex is translocated into the mitochondria. The
Prdx6-TRAF6 complex inhibits the association of ECSIT to
TRAF6 in the mitochondria, resulting in the inhibition of mROS
production.
Prdx6 Is Negatively Involved in NF-κB
Activation Induced by TLR4 Stimulation
Beyond the role of TRAF6-ECSIT in mitochondria, it has
been reported that the complex also plays a pivotal role
for the activation of NF-κB in Toll/IL-1 signal transduction
pathways (Kopp et al., 1999). Interestingly, a previous report
has shown that the deletion of peroxiredoxin-6 exacerbates
lipopolysaccharide-induced inflammation with increased
oxidative stress and inflammatory responses (Yang et al., 2011).
Based on the above results that Prdx6 interrupts the molecular
interaction between TRAF6 and ECSIT, we supposed that
the negative regulation of Prdx6 in TLR4 signaling might be
implicated in the inhibition of TRAF6-ECSIT formation in the
cytoplasm. As expected, overexpression of Prdx6 in 293/TLR4
cells significantly led to suppressions of NF-κB activity and
p65-DNA binding activity induced by TLR4 stimulation (Figures
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FIGURE 3 | Prdx6 interacts with the TRAF-C domain of TRAF6. (A) HEK293T cells were transiently transfected with vector control, Flag-TRAF6, or Myc-ECSIT,
as indicated. After 38 h, immunoprecipitation (IP) assay with anti-Flag antibody was performed, followed by immune blotting (IB) with antibodies to anti-Myc or
anti-Flag. (B) HEK293T cells were transiently transfected with vector control, Flag-TRAF6, or Myc-Prdx6, as indicated. After 38 h, IP assay with anti-Flag antibody was
performed, followed by IB with antibodies to anti-Myc or anti-Flag. (C) Schematic representation of TRAF6 truncated mutants used in this study. Each truncated
mutant was generated, as described in Materials and Methods. (D) HEK293T cells were transfected with vector control, Myc-Prdx6, Flag-TRAF6 wild type (wt),
Flag-TRAF6 110-522, Flag-TRAF6 260-522, or Flag-TRAF6 349-522, as indicated. At 38 h after transfection, transfected cells were extracted, immunoprecipitated
with anti-Myc antibody, and then an IB assay was performed with anti-Flag or anti-Myc antibody. (E) HEK293T cells were vector control transfected or transfected
with Myc-ECSIT, Flag-TRAF6 wt, Flag-TRAF6 110-522, Flag-TRAF6 260-522, or Flag-TRAF6 349-522, as indicated. At 38 h after transfection, transfected cells were
extracted, immunoprecipitated with anti-Flag antibody, and then an IB assay was performed with anti-Flag or anti-Myc antibody. (F) A schematic model of the
molecular interaction between TRAF6 and Prdx6 or ECSIT.
S5A,B). To confirm the functional roles of Prdx6 in TLR4
signaling for the activation of NF-κB, Ctrl and Prdx6KD THP-1
cells were stimulated with or without LPS, and NF-κB activities
were measured using a luciferase assay. Upon LPS stimulation,
NF-κB activity was markedly higher in Prdx6KD THP-1 cells
than in Ctrl THP-1 cells, whereas the activity was significantly
attenuated by the expression of Prdx6 in both Ctrl THP-1
and Prdx6KD THP-1 cells (Figure 5A). Furthermore, p65- or
p50-DNA binding activity was also enhanced in Prdx6KD THP-1
cells compared with Ctrl THP-1 cells (Figure 5B, p65; Figure 5C,
p50). Consistently, the production of the proinflammatory
cytokines IL-6 and IL-1β was significantly higher in Prdx6KD
THP-1 cells treated with LPS than in Ctrl THP-1 cells (Figure 5D,
IL-6; Figure 5E, IL-1β). To further verify the functional effect
of Prdx6, THP-1 cells were transiently transfected with vector
control, Flag-ECSIT, Flag-TRAF6, or Flag-ECSIT and Flag-
TRAF6 in the presence or absence of Myc-Prdx6, and then
NF-κB activity and IL-6 production were measured in response
to TLR4 stimulation. The overexpression of ECSIT, TRAF6,
or ECSIT and TRAF6 enhanced NF-κB reporter activity and
IL-6 production, as compared to vector control transfectant
(Figures 5F,G, column 2 vs. column 4, column 6, and column
8). In contrast, these activities were markedly attenuated by the
overexpression of Prdx6 (Figures 5F,G: column 4 vs. column 5,
column 6 vs. column 7, and column 8 vs. column 9), suggesting
Prdx6 is negatively involved in the TLR4-induced NF-κB
activation.
Next, we confirmed whether Prdx6 affects expression of
NF-κB-dependent genes by TLR4 stimulation. Ctrl THP-1 and
Prdx6KD THP-1 cells were untreated or treated with LPS
for different times (Figure 6A), and microarray analysis was
performed to evaluate gene expression. Upon LPS stimulation,
NF-κB-dependent gene expressions sorted out from microarray
data were markedly elevated in Prdx6KD THP-1 cells, as
compared with those of Ctrl THP-1 cells (Table S1; Figure 6A,
Prdx6KD vs. Ctrl THP-1 cells). To verify their expression, we
performed quantitative real-time PCR analysis with specific
primers targeted to IL-1β, IL-8, NFκB1, CD44, RELB, and CCL5
genes. As expected, these genes were up-regulated in Ctrl THP-1
cells treated with LPS in a time-dependent manner (Figure 6B,
open bars). In Prdx6KD THP-1 cells, interestingly, these genes
were significantly elevated, as compared with those of Ctrl THP-1
cells (Figure 6B, open bars in Ctrl vs. closed red bars in Prdx6KD).
DISCUSSION
The phagocytic response in the innate immune system involves
the production of ROS via the phagosomal NADPH-oxidase-
dependent respiratory burst. This is a necessary effector response
for the destruction of intracellular microbes (Underhill and
Ozinsky, 2002; Lambeth, 2004). In addition to NADPH-
oxidase, the mitochondrial oxidative phosphorylation machinery
generates ROS when electrons prematurely escape oxidative
phosphorylation complexes I and III, and react with molecular
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FIGURE 4 | Prdx6 interrupts the TRAF6-ECSIT interaction. (A) HEK293T cells were transfected with vector control, Flag-TRAF6 349-522, or Myc-Prdx6, as
indicated. At 38 h after transfection, transfected cells were extracted, immunoprecipitated with anti-Flag antibody, and then an IB assay was performed with anti-Flag
or anti-Myc antibody. (B) HEK293T cells were transfected with vector control, Flag-TRAF6 349-522, or Myc-ECSIT, as indicated. At 38 h after transfection, transfected
cells were extracted, immunoprecipitated with anti-Flag antibody, and then an IB assay was performed with anti-Flag or anti-Myc antibody. (C) HEK293T cells were
transfected with vector control, Flag-TRAF6, Myc-ECSIT, or different concentrations of Myc-Prdx6, as indicated. At 38 h after transfection, transfected cells were
extracted, immunoprecipitated with anti-Flag antibody, and then an IB assay was performed with anti-Flag or anti-Myc antibody. (D) Ctrl THP-1 and Prdx6KD THP-1
cells were treated with or without LPS (500 ng/ml) for 60min, respectively. IP assay was performed in lysates with IgG antibody as control and anti-TRAF6 antibody,
and then IB assay was performed with anti-TRAF6, anti-ECSIT, and anti-Prdx6 antibodies. (E) Model of how Prdx6 inhibits the production of mROS through the
inhibition of the interaction between TRAF6 and ECSIT.
oxygen to generate superoxide (Murphy, 2009; Koopman et al.,
2010). The regulatory mechanisms by which mROS is produced
by innate immune signaling could be essential for antibacterial
responses, with signal transmission from phagosomes acting
to recruit mitochondria for effective phagosome-mitochondrion
function and bactericidal activity (West et al., 2011; Geng et al.,
2015). TLR-mediated signaling induces the generation of mROS
by the translocation of mitochondria to phagosomes, which is
mediated by the assembly of a complex of the ubiquitin ligase
TRAF6 and the mitochondrial complex I–assembly factor ECSIT
(West et al., 2011). Interestingly, a recent study has shown that
Mst1 and Mst2 kinases are critically involved in the optimal ROS
production and bactericidal activity by increasing the activation
of the small GTPase Rac and mitochondrial trafficking and the
mitochondrion-phagosome association through the assembly of
a TRAF6-ECSIT complex (Geng et al., 2015). These studies
strongly suggest a pivotal role of the assembly of TRAF6-
ECSIT complex induced by TLR stimulation for the production
of mROS and bactericidal activity. In this study, we have
demonstrated that Prdx6 negatively regulates the generation of
mROS. Prdx6 is localized into the mitochondria in response to
LPS stimulation. Biochemical study revealed that Prdx6 wild type
and C47A Prdx6 catalytic mutant were interacted with TRAF6
in similar levels (Figure S6, lanes 2 vs. 3 in IB: Myc), supposing
that the enzymatic mutant of Prdx6 does not affect on the
molecular interaction between Prdx6 and TRAF6. Moreover, the
Prdx6-TRAF6 interaction inhibited the association of TRAF6-
ECSIT complex. Interestingly, we found that the mitochondrial
localization of Prdx6 was significantly attenuated in the TRAF6-
knockdown THP-1 cells in response to LPS stimulation, as
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FIGURE 5 | Prdx6-knockdown THP-1 cells display enhanced NF-κB activity induced by TLR4 stimulation. (A) Ctrl and Prdx6KD cells were transfected with a
vector control or Myc-Prdx6 vector together with pBIIx-luc and Renilla luciferase vector. Thirty six hours after transfection, the Myc-Prdx6 expression was confirmed
by Western blotting (left). Cells were untreated or treated with LPS (200 ng/ml) for 6 h and then analyzed for luciferase activity. Results are expressed as the
fold-induction in luciferase activity relative to that in untreated cells. All error bars represent ± SEM of the mean from triplicate samples. *p < 0.05. (B,C) Ctrl and
Prdx6KD cells were untreated or treated with LPS (200 ng/ml) for 6 h and then analyzed for p65- or p50-DNA binding activity using the manufacturer’s protocol. All
error bars represent ± SEM of the mean from triplicate samples. *p < 0.05. (D,E) Ctrl and Prdx6KD cells were untreated or treated with LPS (200 ng/ml) for 9 h, and
production of IL-6 (D) and IL-1β (E) were analyzed by enzyme-linked immunosorbent assay (ELISA). All error bars represent ± SEM of the mean from triplicate
samples. *p < 0.05. (F) THP-1 cells were transfected with vector control, Flag-TRAF6, Flag-ECSIT, or Myc-Prdx6 vector, as indicated, together with pBIIx-luc and
Renilla luciferase vector. Thirty six hours after transfection, cells were untreated or treated with LPS (200 ng/ml) for 6 h and then analyzed for luciferase activity. Results
are expressed as the fold-induction in luciferase activity relative to that in untreated cells. All error bars represent ± SEM of the mean from triplicate samples. *p < 0.05
and **p < 0.01, #p = 0.0006, ##p = 0.0013, ###p = 0.0097, ####p = 0.0189. (G) THP-1 cells were transfected with vector control, Flag-TRAF6,
Flag-ECSIT, or Myc-Prdx6 vector, as indicated. Thirty six hours after transfection, cells were untreated or treated with LPS (200 ng/ml) for 9 h, and production of IL-6
was analyzed by enzyme-linked immunosorbent assay (ELISA). All error bars represent ± SEM of the mean from triplicate samples. *p < 0.05 and **p < 0.01, p =
0.0002, ##p = 0.0119, ###p = 0.0012, ####p = 0.0042.
compared with that of control THP-1 cells (Figure S7, lanes 6
vs. 8 in IB: Prdx6), indicating that the localization of Prdx6
might be accompanied with TRAF6. Furthermore, we found
that the mROS level was significantly higher in Prdx6KD THP-
1 cells than in Ctrl THP-1 cells, and the Salmonella survival rate
was markedly attenuated in Prdx6KD THP-1 cells. These results
suggest that Prdx6 might negatively regulate the generation of
mROS through the interruption of TRAF6-ECSIT complex, and
involve bactericidal activity.
Besides the functional role of TRAF6-ECSIT complex in the
mitochondria, TRAF6 and ECSIT proteins have been critically
implicated in the Toll/IL-1 signal transduction pathways (Kopp
et al., 1999; Wi et al., 2014; Mi Wi et al., 2015). TRAF6 is a
member of the TRAF family with E3 ubiquitin ligase activity. It
is crucial in activating IκB kinase (IKK) and mitogen-activated
protein kinase, leading to activation of NF-κB (Akira et al., 2006).
ECSIT was first discovered as an adaptor protein involved in
coupling TLR and TRAF6 to MEKK-1 and NF-κB (Kopp et al.,
1999). In addition, our recent studies revealed new regulatory
roles for the activation of NF-κB in response to TLR4 stimulation
(Wi et al., 2014; Mi Wi et al., 2015). ECSIT forms the signaling
complex, including TAK1 and TRAF6, and the complex is pivotal
in TLR4-mediated signals to activate NF-κB (Wi et al., 2014).
ECSIT also specifically interacts with p65/p50 NF-κB proteins
through the ubiquitination of the ECSIT lysine 372 residue, and
is then translocated into the nucleus resulting in the increase
of proinflammatory cytokines and the enhancement of NF-κB-
dependent gene expression in response to TLR4 stimulation (Mi
Wi et al., 2015). Interestingly, we found that the overexpression
of Prdx6 led to the inhibition of NF-κB induced by TLR4,
whereas Prdx6KD THP-1 cells displayed enhanced production
of pro-inflammatory cytokines including interleukin-6 and -
1β, and the up-regulation of NF-κB-dependent genes induced
by TLR4 stimulation. Having shown that Prdx6 interacted
with TRAF6, and the Prdx6-TRAF6 interaction inhibited the
association of ECSIT protein to TRAF6, we speculate that
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FIGURE 6 | NF-κB-dependent gene expressions induced by TLR4 are increased in Prdx6KD THP-1 cells. (A) Comparison of NF-κB-dependent gene
expression in control (Ctrl) vs. Prdx6KD THP-1 cells. Ctrl and Prdx6KD THP-1 cells were untreated or treated with LPS (200 ng/ml) for different times, as indicated.
Total RNA was extracted, and microarray analysis was performed, as described in Methods. NF-κB-dependent gene expressions were compared in Ctrl THP-1 vs.
Prdx6KD THP-1 cells. Gene expression levels are indicated with color bars (Red, up-regulated genes; green, down-regulated genes) (B) Ctrl and Prdx6KD THP-1 cells
(Continued)
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FIGURE 6 | Continued
were untreated or treated with LPS (200 ng/ml) for different times, as indicated. Total RNA was extracted, and quantitative RT-PCR analysis with specific primers to
IL-1β, IL-8, NFκB1, CD44, RELB, and CCL5, was performed. All error bars represent ± SEM of the mean from triplicate samples. IL-1β:#p = 0.0014 and ##p =
0.0179; IL-8: #p = 0.0015; NFκB1:#p = 0.0034 and ##p = 0.0004; CD44: #p = 0.0222 and ##p = 0.0063; RELB: #p = 0.0072 and ##p = 0.0102: CCL5;
#p = 0.0078 and ##p = 0.0112.
FIGURE 7 | Model detailing the negative role of Prdx6 in mROS generation and NF-κB activation induced by TLR4. On TLR4 stimulation, MyD88 binds to
the cytoplasmic portion of the TLRs through interactions between individual TIR domains. IRAKs, such as IRAK-4 and IRAK- 1, and TRAF6 are recruited to the
receptor, and then phosphorylated IRAK-1 (by IRAK-4) dissociates from the receptor together with TRAF6. TRAF6 translocates into the mitochondria and associates
with ECSIT-OXPHOS complex I, leading to the production of mROS (blue arrow line). In the meantime, the TRAF6 further associates with TAB1–TAK1–TAB2 complex
through the cytoplasmic ECSIT protein and activates IKKs complex, eventually leading to activations of NF-κB (black arrow line). We speculate that Prdx6 interacts
with TRAF6, which leads to two inhibitory effects (red arrow line); one is to inhibit the association of TRAF6-ECSIT- OXPHOS complex I in the mitochondria for mROS
production, another is to inhibit the interaction between TRAF6 and ECSIT and thereby leads to the inhibition of associations of TAB1–TAK1–TAB2 complex to
TRAF6-ECSIT for the activation of IKKs.
Prdx6 might be negatively involved in the TLR4-induced NF-κB
activation through the inhibition of interaction between TRAF6
and ECSIT.
The present findings demonstrate that Prdx6 inhibits the
association of TRAF6-ECSIT complex in mitochondria and
cytoplasm. The interruption of assembly of TRAF6-ECSIT
complex is critical in the suppression of mROS generation
in mitochondria and the inhibition of NF-κB activation in
cytoplasm induced by TLR4, respectively. Having shown essential
roles of TRAF6-ECSIT complex exerting mROS regulation and
NF-κB activation, we propose a plausible model of the negative
regulation of Prdx6 in these pathways. As depicted in Figure 7,
upon TLR4 stimulation MyD88 binds to the cytoplasmic portion
of the TLRs through interactions between individual TIR
domains. IRAKs including IRAK-4 and IRAK-1, and TRAF6 are
recruited to the receptor. IRAK-1 is phosphorylated by IRAK-4
and dissociates from the receptor together with TRAF6. TRAF6
further interacts with TAK1, TAB1, and TAB2 leading to the
activation of IKKs. Simultaneously, TRAF6 translocates into
the mitochondria, where mROS is produced by the OXPHOS
complex I associated with the TRAF6-ECSIT proteins, leading
to the bactericidal activity. In the meantime, Prdx6 interacts
with TRAF6, and that translocates into the mitochondria. The
TRAF6-Prdx6 complex does not associate with the ECSIT-
OXPHOS complex I because Prdx6masks the interaction domain
of TRAF6 to ECIST, resulting in the suppression of mROS
production. Additionally, the interaction of Prdx6 to TRAF6 in
the cytoplasm inhibits the formation of TRAF6-ECSIT complex,
which has been critically implicated in the activation of NF-
κB induced by TLR stimulation (Kopp et al., 1999; Wi et al.,
2014; Mi Wi et al., 2015), resulting in the inhibition of NF-κB
activation.
Inflammatory signals including TLRs need to be tightly
controlled in the host because excessive or prolonged
inflammatory responses to microbial infection can lead to
harmful effects to the host (Beutler, 2004). Varied mechanisms
and cellular proteins capable of interrupting TLRs-mediated
signaling have been proposed and reported (Trompouki et al.,
2003; Boone et al., 2004; Liew et al., 2005; Zhang et al., 2013; Jiao
et al., 2015). In line with these findings, our data may contribute
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to the understanding of cellular and molecular regulations
in limiting inflammatory responses, thereby advancing the
development of therapeutic targets capable of regulating
inflammatory responses.
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